UniProt ID | ARP19_HUMAN | |
---|---|---|
UniProt AC | P56211 | |
Protein Name | cAMP-regulated phosphoprotein 19 | |
Gene Name | ARPP19 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 112 | |
Subcellular Localization | Cytoplasm. | |
Protein Description | Protein phosphatase inhibitor that specifically inhibits protein phosphatase 2A (PP2A) during mitosis. When phosphorylated at Ser-62 during mitosis, specifically interacts with PPP2R2D (PR55-delta) and inhibits its activity, leading to inactivation of PP2A, an essential condition to keep cyclin-B1-CDK1 activity high during M phase. May indirectly enhance GAP-43 expression.. | |
Protein Sequence | MSAEVPEAASAEEQKEMEDKVTSPEKAEEAKLKARYPHLGQKPGGSDFLRKRLQKGQKYFDSGDYNMAKAKMKNKQLPTAAPDKTEVTGDHIPTPQDLPQRKPSLVASKLAG | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 (in isoform 2) | Acetylation | - | 8.48 | - | |
2 | Phosphorylation | ------MSAEVPEAA ------CCCCCCCCC | 32.89 | 25159151 | |
2 | Acetylation | ------MSAEVPEAA ------CCCCCCCCC | 32.89 | 19413330 | |
6 (in isoform 2) | Phosphorylation | - | 19.60 | 25849741 | |
7 (in isoform 2) | Phosphorylation | - | 63.14 | 25849741 | |
10 | Phosphorylation | AEVPEAASAEEQKEM CCCCCCCCHHHHHHH | 43.17 | 25159151 | |
22 | Phosphorylation | KEMEDKVTSPEKAEE HHHHHHCCCHHHHHH | 44.28 | 29255136 | |
23 | Phosphorylation | EMEDKVTSPEKAEEA HHHHHCCCHHHHHHH | 33.77 | 29255136 | |
26 | Acetylation | DKVTSPEKAEEAKLK HHCCCHHHHHHHHHH | 65.56 | 19608861 | |
31 | Acetylation | PEKAEEAKLKARYPH HHHHHHHHHHHHCCC | 54.52 | 7709657 | |
33 | Acetylation | KAEEAKLKARYPHLG HHHHHHHHHHCCCCC | 30.06 | 18604429 | |
35 | Methylation | EEAKLKARYPHLGQK HHHHHHHHCCCCCCC | 43.88 | - | |
36 | Phosphorylation | EAKLKARYPHLGQKP HHHHHHHCCCCCCCC | 10.40 | - | |
42 (in isoform 2) | Ubiquitination | - | 43.78 | 21890473 | |
42 | Acetylation | RYPHLGQKPGGSDFL HCCCCCCCCCCCHHH | 43.78 | 23749302 | |
42 | Ubiquitination | RYPHLGQKPGGSDFL HCCCCCCCCCCCHHH | 43.78 | - | |
46 | Phosphorylation | LGQKPGGSDFLRKRL CCCCCCCCHHHHHHH | 30.98 | 25159151 | |
58 | Ubiquitination | KRLQKGQKYFDSGDY HHHHHCCCHHCCCCH | 57.46 | 21890473 | |
58 (in isoform 1) | Ubiquitination | - | 57.46 | 21890473 | |
58 | Acetylation | KRLQKGQKYFDSGDY HHHHHCCCHHCCCCH | 57.46 | 88691 | |
59 | Phosphorylation | RLQKGQKYFDSGDYN HHHHCCCHHCCCCHH | 12.53 | 22167270 | |
62 | Phosphorylation | KGQKYFDSGDYNMAK HCCCHHCCCCHHHHH | 24.54 | 19664994 | |
65 | Phosphorylation | KYFDSGDYNMAKAKM CHHCCCCHHHHHHHH | 15.46 | 25463755 | |
69 | Ubiquitination | SGDYNMAKAKMKNKQ CCCHHHHHHHHCCCC | 37.46 | 2189047 | |
71 | Ubiquitination | DYNMAKAKMKNKQLP CHHHHHHHHCCCCCC | 50.10 | - | |
79 | Phosphorylation | MKNKQLPTAAPDKTE HCCCCCCCCCCCCCC | 44.00 | 20068231 | |
84 | Acetylation | LPTAAPDKTEVTGDH CCCCCCCCCCCCCCC | 45.59 | 25953088 | |
85 | Phosphorylation | PTAAPDKTEVTGDHI CCCCCCCCCCCCCCC | 42.97 | 26074081 | |
88 | Phosphorylation | APDKTEVTGDHIPTP CCCCCCCCCCCCCCC | 30.57 | 26074081 | |
94 | Phosphorylation | VTGDHIPTPQDLPQR CCCCCCCCCCCCCCC | 32.74 | 26074081 | |
94 | O-linked_Glycosylation | VTGDHIPTPQDLPQR CCCCCCCCCCCCCCC | 32.74 | OGP | |
102 | Ubiquitination | PQDLPQRKPSLVASK CCCCCCCCHHHHHHH | 33.44 | - | |
104 | Phosphorylation | DLPQRKPSLVASKLA CCCCCCHHHHHHHHC | 38.21 | 23401153 | |
108 | Phosphorylation | RKPSLVASKLAG--- CCHHHHHHHHCC--- | 22.26 | 23927012 | |
109 | Acetylation | KPSLVASKLAG---- CHHHHHHHHCC---- | 32.39 | 19608861 |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
62 | S | Phosphorylation |
| - |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ARP19_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-109, AND MASS SPECTROMETRY. |